AstraZeneca
EsoBiotec, now part of AstraZeneca, is seeking a Senior Scientist Vector Engineering to drive innovation and development of their lentiviral vector therapeutic platform in Cambridge, MA. The role involves designing, building, and validating novel lentiviral vectors for in vivo cell therapy applications while collaborating with cross-functional teams to align vector designs with product requirements. This position requires a PhD with postdoctoral experience and expertise in viral vector engineering, gene editing, and immunology to contribute to life-changing treatments.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Scientist
Asimov
Scientist
ASTARPRD
Exec Director, Viral Vector Process Development
Gilead Sciences
Senior Scientist – Functional Genomics
Amgen
Director of Vector Engineering and Manufacturing Quality - Cell Therapy
Marriott International
Senior Associate Scientist, AAV Cell Line Development (Contractor)
Asimov